Aclaris Therapeutics Inc. (ACRS)
ACRS trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$3.47
-3.61% on the day
Market cap
$510.8M
Small cap
Revenue · 2025
$7.8M
-58.2% on 2024
Net income · 2025
-$64.9M
-829.6% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | ACRS on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2015 |
| SEC CIK | 0001557746 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $7.8M |
| Net income | -$64.9M |
| Operating income | -$76.4M |
| Net margin | -829.6% |
| Operating margin | -975.9% |
| Revenue growth | -58.2% |
| Cash | $20.0M |
| Total assets | $160.5M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 65.3× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3ASR | 2026-08-06 |
| Latest annual report | 10-K | 2026-02-26 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report | 8-K | 2026-08-06 |
| Latest proxy | DEFA14A | 2026-04-23 |
Source: SEC EDGAR submissions feed, 867 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -0.4% |
| 1 month | -38.7% |
| 3 months | -36.8% |
| Year to date | +12.5% |
| 1 year | +77.2% |
| From 52-week high | -48.2% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| MPLT | MapLight Therapeutics Inc. | $7.88 | -8.43% | $510.1M |
| CTMX | CytomX Therapeutics Inc. | $2.33 | -3.93% | $506.6M |
| DRUG | Bright Minds Biosciences Inc. | $51.36 | -4.91% | $504.3M |
| PBYI | Puma Biotechnology Inc | $10.12 | -1.65% | $522.4M |
| EOLS | Evolus Inc. | $7.51 | -3.10% | $496.0M |
| BLSM | BlossomHill Therapeutics Inc. | $15.48 | -10.37% | $492.0M |
| MNPR | Monopar Therapeutics Inc. | $72.08 | -6.45% | $483.8M |
| CBIO | Crescent Biopharma Inc. | $12.91 | -10.72% | $479.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier